These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4345716)

  • 21. The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
    Phillips MI; Heininger F; Toffolo S
    Regul Pept; 1996 Oct; 66(1-2):3-11. PubMed ID: 8899885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme blockade and thirst.
    DiNicolantonio R
    Clin Exp Hypertens A; 1984; 6(10-11):2025-9. PubMed ID: 6099774
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of the renin-angiotensin system in drinking of seawater-adapted eels Anguilla japonica: a reevaluation.
    Takei Y; Tsuchida T
    Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1105-11. PubMed ID: 10956272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.
    Gavras H; Brunner HR; Gavras I; Laragh JH
    Lancet; 1974 Aug; 2(7876):353. PubMed ID: 4136088
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of the converting enzyme inhibitor SQ-20881 on urinary excretion of prostaglandin E2 in the rat: influence of pretreatment with deoxycorticosterone.
    Barr JG; Diz D; Kauker ML; Nasjletti A
    J Pharmacol Exp Ther; 1980 Oct; 215(1):172-5. PubMed ID: 6161243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
    Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
    J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amastatin potentiates drinking elicited by osmotic stimuli: evidence for peptidergic mediation of intracellular dehydration-induced thirst.
    Sullivan MJ; Johnson AK
    Brain Res; 1992 Sep; 590(1-2):271-6. PubMed ID: 1422835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of intracerebroventricular administration of tonin on water drinking and blood pressure in rats.
    Kondo K; Saruta T; Garcia R; Boucher R
    Endocrinol Jpn; 1980 Oct; 27(5):567-71. PubMed ID: 6165574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to angiotensins I and II and to AI-converting-enzyme inhibitor in a shark.
    Opdyke DF; Holcombe R
    Am J Physiol; 1976 Dec; 231(6):1750-3. PubMed ID: 12664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats.
    Polidori C; Ciccocioppo R; De Caro G; Massi M
    Peptides; 1998; 19(1):149-55. PubMed ID: 9437747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
    Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
    [No Abstract]   [Full Text] [Related]  

  • 35. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
    Vollmer RR; Boccagno JA
    Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II mediates drinking elicited by eating in the rat.
    Kraly FS; Corneilson R
    Am J Physiol; 1990 Feb; 258(2 Pt 2):R436-42. PubMed ID: 2178449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.